Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia

Eastern asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma

(2010) Winnie Yeo et al.   BMC CANCER

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

(2010) Masao Omata et al.   Hepatology International

Liver Cancer Working Group Report

(2010) M. Kudo et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

The Challenge of Prognosis and Staging for Hepatocellular Carcinoma

(2010) J. A. Marrero et al.   ONCOLOGIST

Positioning and Indication of Sorafenib in the Treatment Algorithm and Real Practice Setting: Western and Eastern Approach – Asian Perspective

(2010) Jung Min Lee et al.   ONCOLOGY

Positioning of a Molecular-Targeted Agent, Sorafenib, in the Treatment Algorithm for Hepatocellular Carcinoma and Implication of Many Complete Remission Cases in Japan

(2010) Masatoshi Kudo et al.   ONCOLOGY

Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects

(2010) Alejandro Forner et al.   SEMINARS IN LIVER DISEASE

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

(2009) Johannes Lammer et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes

(2009) Riad Salem et al.   GASTROENTEROLOGY

Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines

(2009) Norihiro Kokudo et al.   JOURNAL OF GASTROENTEROLOGY

Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009

(2009) Donald Poon et al.   LANCET ONCOLOGY

The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma – Survival analysis of 3892 patients

(2008) Jing-Houng Wang et al.   EUROPEAN JOURNAL OF CANCER

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Validation of a New Prognostic Staging System for Hepatocellular Carcinoma: A Comparison of the Biomarker-Combined Japan Integrated Staging Score, the Conventional Japan Integrated Staging Score and the BALAD Score

(2008) Satoshi Kitai et al.   ONCOLOGY